E OGrady
Overview
Explore the profile of E OGrady including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finnegan R, OGrady E, Smyth A, Ryan S, Williamson M
Ir Med J
. 2020 Jul;
113(5):70.
PMID: 32603566
Aim The aim of this study was to explore risk factors for acute changes in lung function following initiation of lumacaftor/ivacaftor (LUM/IVA) in children with cystic fibrosis. Methods Retrospective review...
2.
Alabraba E, Joshi H, Bird N, Griffin R, Sturgess R, Stern N, et al.
Eur J Surg Oncol
. 2019 Apr;
45(9):1660-1667.
PMID: 31014988
Background: Primary hepatobiliary cancer incidence in the UK is rising and survival rates are low. Surgery is the main curative option for these cancers, but multimodality therapies are expanding. The...
3.
OGrady E, Power D, Tan S
J Hand Surg Eur Vol
. 2017 Jun;
42(9):959-960.
PMID: 28605942
No abstract available.
4.
Jones R, Malik H, Fenwick S, Terlizzo M, OGrady E, Stremitzer S, et al.
Eur J Surg Oncol
. 2016 Aug;
42(12):1866-1872.
PMID: 27561844
Purpose: Perioperative chemotherapy confers a 3-year progression free survival advantage following resection of colorectal liver metastases (CRLM), but is associated with significant toxicity. Chemoembolisation using drug eluting PVA microspheres loaded...
5.
Cassar M, OGrady E, Al Furajii H, Caulfield R, Cahill R
Colorectal Dis
. 2016 Jul;
18(9):920.
PMID: 27418408
No abstract available.
6.
OGrady E, Doyle M, Fitzgerald C, Mortell A, Murray D
Ir Med J
. 2015 Jan;
107(10):328-9.
PMID: 25551902
A 2½ year old girl attended our facility following attack by a tapir at a city zoo. She sustained multiple injuries including a forearm laceration and multiple perforating wounds to...
7.
Jones R, Stattner S, Dunne D, OGrady E, Smethurst A, Terlizzo M, et al.
Eur J Surg Oncol
. 2013 Aug;
39(10):1122-8.
PMID: 23928482
Introduction: Transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) allows targeted delivery of irinotecan direct to liver tissue and colorectal liver metastases (CRLM). Accurate assessment of tumour response to therapy is...
8.
Jones R, Sutton P, Greensmith R, Santoyo-Castelazo A, Carr D, Jenkins R, et al.
Cancer Chemother Pharmacol
. 2013 Jun;
72(2):359-68.
PMID: 23756919
Purpose: The response of colorectal liver metastases to the cytotoxic agent irinotecan varies widely. Attempts to correlate tumour metabolism with response have been mixed. This study investigated the hepatic metabolism...
9.
Allotey R, Mohan V, McDermott M, Deepa R, Premalatha G, Hassan Z, et al.
Genes Immun
. 2004 Oct;
5(8):648-52.
PMID: 15483661
Mutations in the EIF2AK3 gene underlie susceptibility to the Wolcott-Rallison syndrome, which is a monogenic disease associated with insulin-deficient neonatal diabetes. Furthermore, suggestive evidence of linkage between type 1 diabetes...
10.